<?xml version="1.0" ?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:seo="http://purl.org/seo/elements/1.0/" version="2.0">
	<channel>
		<title>TMX Newsfile Pharmaceuticals News Releases</title>
		<link>https://feeds.newsfilecorp.com/industry/medical-pharmaceuticals</link>
		<description>Last 10 Pharmaceuticals news releases from TMX Newsfile. Contact us for a custom full-bodied RSS feed complete with exchange and ticker data.</description>
		<language>en</language>
		<copyright>CopyRight (c) 2026, Newsfile Corp. All Rights Reserved.</copyright>
		<managingEditor>office@newsfilecorp.com (Newsfile Corp.)</managingEditor>
		<webMaster>office@newsfilecorp.com (Newsfile Corp.)</webMaster>
		<lastBuildDate>Fri, 23 Oct 2026 19:00:23 -0400</lastBuildDate>
		<image>
			<url>https://www.newsfilecorp.com/images/tmx-newsfile-wire-logo.png</url>
			<title>TMX Newsfile Pharmaceuticals News Releases</title>
			<link>https://feeds.newsfilecorp.com/industry/medical-pharmaceuticals</link>
		</image>
		<atom:link rel="self" type="application/rss+xml" href="https://feeds.newsfilecorp.com/industry/medical-pharmaceuticals"/>
		<item xml:lang="en">
			<title>Unbuzzd Wellness Announces Closing of Private Placement Financing</title>
			<link>https://www.newsfilecorp.com/release/320749/Unbuzzd-Wellness-Announces-Closing-of-Private-Placement-Financing</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/320749/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Vancouver, British Columbia--(Newsfile Corp. - October 23, 2026) - Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzd™, is pleased to announce that it has completed its non-brokered private placement financing (the "Offering") in two tranches for aggregate gross proceeds of $1,080,000 through the issuance of an aggregate of 5,400,000 common shares in the share capital of the Company (the "Shares") at a price of $0.20 per Share.The Company closed the first tranche of...</description>
			<pubDate>Fri, 23 Oct 2026 19:00:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/320749/Unbuzzd-Wellness-Announces-Closing-of-Private-Placement-Financing</guid>
		</item>
		<item xml:lang="en">
			<title>Defence Therapeutics Announces Convertible Debenture Interest Payment</title>
			<link>https://www.newsfilecorp.com/release/320679/Defence-Therapeutics-Announces-Convertible-Debenture-Interest-Payment</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/320679/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Montreal, Quebec--(Newsfile Corp. - October 23, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology company developing next-generation precision oncology therapeutics using its proprietary Accum® drug-delivery platform, is pleased to announce convertible debentures interest payment in common shares of the Company.  The Company announces that, in accordance with the terms and conditions of convertible debentures...</description>
			<pubDate>Fri, 23 Oct 2026 16:15:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/320679/Defence-Therapeutics-Announces-Convertible-Debenture-Interest-Payment</guid>
		</item>
		<item xml:lang="en">
			<title>Global Hemp Group Appoints Mickey Goldstein as Chief Financial Officer, Appoints Davidson &amp; Company as Auditor</title>
			<link>https://www.newsfilecorp.com/release/320599/Global-Hemp-Group-Appoints-Mickey-Goldstein-as-Chief-Financial-Officer-Appoints-Davidson-Company-as-Auditor</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/320599/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Vancouver, British Columbia--(Newsfile Corp. - October 23, 2026) - Global Hemp Group Inc. (CSE: GHG) (FSE: GHG0) (OTC PINK: GBHPF) ("GHG" or the "Company") is pleased to announce the appointment of Mickey Goldstein, CPA, CA, as Chief Financial Officer, effective immediately. Ms. Goldstein succeeds Christopher Cherry.Ms. Goldstein is Director, Accounting Advisory at Crowe MacKay LLP, where she provides strategic financial and advisory services to private and public companies across North America....</description>
			<pubDate>Fri, 23 Oct 2026 09:59:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/320599/Global-Hemp-Group-Appoints-Mickey-Goldstein-as-Chief-Financial-Officer-Appoints-Davidson-Company-as-Auditor</guid>
		</item>
		<item xml:lang="en">
			<title>PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement</title>
			<link>https://www.newsfilecorp.com/release/320512/PreveCeutical-Closes-Initial-Tranche-of-NonBrokered-Private-Placement</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/320512/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Vancouver, British Columbia--(Newsfile Corp. - October 22, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased announce that, further to its news release dated September 28, 2026, it has closed an initial tranche (the "Initial Tranche") of its previously announced $600,000 non-brokered private placement (the "Offering"), which Initial Tranche consisted of the issuance of 5,200,000 units (each, a "Unit") of the Company at a...</description>
			<pubDate>Thu, 22 Oct 2026 17:24:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/320512/PreveCeutical-Closes-Initial-Tranche-of-NonBrokered-Private-Placement</guid>
		</item>
		<item xml:lang="en">
			<title>Telescope Innovations to Attend the 2026 Planet Microcap Investment Conference in Toronto</title>
			<link>https://www.newsfilecorp.com/release/320327/Telescope-Innovations-to-Attend-the-2026-Planet-Microcap-Investment-Conference-in-Toronto</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/320327/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Vancouver, British Columbia--(Newsfile Corp. - October 22, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a leading developer of Physical AI systems, including Self-Driving Laboratories ("SDL"), enabling technologies, and services for the global pharmaceutical and high-value chemical industries, today announced that members of its leadership team will attend the Planet MicroCap Toronto Investment Conference on  October 27, 28 and 29th at...</description>
			<pubDate>Thu, 22 Oct 2026 08:00:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/320327/Telescope-Innovations-to-Attend-the-2026-Planet-Microcap-Investment-Conference-in-Toronto</guid>
			<atom:subtitle>Leading Canadian developer of Physical AI for the chemical and pharmaceutical industries to meet investors October 27, 28 and 29</atom:subtitle>
		</item>
		<item xml:lang="en">
			<title>Custom Health to Close the Market at the TSX on October 22, 2026, and Announces Appointments of Chief Commercial and Strategy Officer and Chief Compliance and Regulatory Officer</title>
			<link>https://www.newsfilecorp.com/release/320083/Custom-Health-to-Close-the-Market-at-the-TSX-on-October-22-2026-and-Announces-Appointments-of-Chief-Commercial-and-Strategy-Officer-and-Chief-Compliance-and-Regulatory-Officer</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/320083/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Custom Health will close the market at the Toronto Stock Exchange on October 22, 2026, to celebrate the Company's recent listing on the TSX Exchange.Mike Palackdharry has been appointed Chief Commercial and Strategy Officer, bringing more than 30 years of experience in commercial strategy, enterprise sales, business development, and strategic partnerships.Christina Garcia has been appointed Chief Compliance and Regulatory Officer, bringing more than 15 years of experience in compliance, privacy,...</description>
			<pubDate>Wed, 21 Oct 2026 06:00:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/320083/Custom-Health-to-Close-the-Market-at-the-TSX-on-October-22-2026-and-Announces-Appointments-of-Chief-Commercial-and-Strategy-Officer-and-Chief-Compliance-and-Regulatory-Officer</guid>
		</item>
		<item xml:lang="en">
			<title>TempraMed Announces LIFE Offering up to C$8 Million to Accelerate Global Expansion and Fulfilment of Forecasted Demand</title>
			<link>https://www.newsfilecorp.com/release/319885/TempraMed-Announces-LIFE-Offering-up-to-C8-Million-to-Accelerate-Global-Expansion-and-Fulfilment-of-Forecasted-Demand</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/319885/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Recent Highlights: Record sales: July 2026 sales were about US$522K1, the best month in the company's history, and August was about US$403K, its second-best. Run rate revenue of ~US$5.5M Sales for the first eight months of 2026 were about US$2.07M, already above the US$1.8M booked for all of 2025.Growing patent portfolio: 4 new global patents granted in 2026, for a total ofGlobal distribution: 15 new and renewed distribution commercial relationships signed in 2026, including direct B2B...</description>
			<pubDate>Tue, 20 Oct 2026 07:00:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/319885/TempraMed-Announces-LIFE-Offering-up-to-C8-Million-to-Accelerate-Global-Expansion-and-Fulfilment-of-Forecasted-Demand</guid>
			<atom:subtitle>Strategic financing to scale the growth of the Company, increase global distribution and fulfill strong pipeline of new distribution agreements and B2B contracts</atom:subtitle>
		</item>
		<item xml:lang="en">
			<title>Herbal Dispatch Expands Offering with New Ontario and Saskatchewan Listings and Increased BC Portfolio</title>
			<link>https://www.newsfilecorp.com/release/319931/Herbal-Dispatch-Expands-Offering-with-New-Ontario-and-Saskatchewan-Listings-and-Increased-BC-Portfolio</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/319931/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Vancouver, British Columbia--(Newsfile Corp. - October 20, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a cannabis commerce and international distribution platform, today announced that four of its Happy Hour SKUs have been listed with the Ontario Cannabis Store ("OCS"). The Company also provided an update on its British Columbia and Saskatchewan distribution. ONTARIO LISTINGSThe following Happy Hour SKUs are expected to begin selling...</description>
			<pubDate>Tue, 20 Oct 2026 06:00:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/319931/Herbal-Dispatch-Expands-Offering-with-New-Ontario-and-Saskatchewan-Listings-and-Increased-BC-Portfolio</guid>
		</item>
		<item xml:lang="en">
			<title>Custom Health Highlights Early Results with BKC Pain Specialists, Supporting Expansion of Chronic Pain Program</title>
			<link>https://www.newsfilecorp.com/release/319917/Custom-Health-Highlights-Early-Results-with-BKC-Pain-Specialists-Supporting-Expansion-of-Chronic-Pain-Program</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/319917/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Custom Health's existing commercial program with BKC Pain Specialists &amp; Regenerative Medicine Clinic in Ohio is demonstrating early results through the integration of in-home medication technology, pharmacy services and pharmacist-led clinical support for patients managing complex chronic pain. The program provides continuous visibility into patients' medication use and experiences between physician visits, enabling personalized patient engagement, pharmacist-led clinical support and more...</description>
			<pubDate>Tue, 20 Oct 2026 06:00:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/319917/Custom-Health-Highlights-Early-Results-with-BKC-Pain-Specialists-Supporting-Expansion-of-Chronic-Pain-Program</guid>
		</item>
		<item xml:lang="en">
			<title>Richards Group Inc. Announces October 2026 Dividend</title>
			<link>https://www.newsfilecorp.com/release/319708/Richards-Group-Inc.-Announces-October-2026-Dividend</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/319708/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Toronto, Ontario--(Newsfile Corp. - October 19, 2026) - Richards Group Inc. (TSX: RIC) (the "Company") announced today its cash dividend for the month ended October 31, 2026 of Cdn$0.11 per share.  This dividend will be to shareholders of record at the close of business on October 30, 2026 and will be payable on November 13, 2026.  Shareholders who are non-residents of Canada may be required to pay all withholding taxes payable in respect of any dividends of income by the Company, whether such...</description>
			<pubDate>Mon, 19 Oct 2026 11:36:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/319708/Richards-Group-Inc.-Announces-October-2026-Dividend</guid>
		</item>
	</channel>
</rss>
